Identification of Acute Intermittent Porphyria Modifying Genes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Identification of Acute Intermittent Porphyria Modifying Genes — Stella

Recruiting

Back to Acute Intermittent Porphyria (AIP) trials

Trial locations(1 site)

United States

Icahn School of Medicine at Mount Sinai, New York, New York

Key details

Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment target

~150 participants

Started

September 2022

Primary completion

June 2026

Age range

12 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov